OR WAIT 15 SECS
The investment doubles the company’s capacity to meet increasing demand for its biologics contract testing and biosimilar characterization services.
BioOutsource, part of Sartorius Stedim Biotech Group, has opened a new facility in Glasgow. The investment follows the increasing demand for the company’s biologics contract testing and biosimilar characterization services. The new facility doubles BioOutsource’s capacity for future growth and will create approximately 50 new jobs for scientific and technical professionals in the next six months, according to the company.